Efficient Construction of Chiral Spiro[benzo[g]chromene-oxindole] Derivatives via Organocatalytic Asymmetric Cascade Cyclization

Abstract

Pyranonaphthoquinone units are common in molecular structures with significant biological and pharmaceutical activities. Herein, the organocatalytic asymmetric cascade Michael cyclization reaction of 2-hydroxynaphthalene-1,4-diones to isatylidene malononitriles has been developed, which provided the desired spiro[4H-benzo[g]chromene-indoline] derivatives in up to 99% yield with up to 99% ee. To illustrate the potential utility of these products, a further transformation was conducted to give a spiropoly­heterocyclic compound in moderate yield without loss of enantioselectivity (>99% ee). Biological evaluation of these spiro[benzo[g]chromene-indoline] derivatives has revealed excellent antiproliferative activity against a number of cancer cell lines, with a high inhibition rate ranging from 93% to 99% at a concentration of 50 μM.

Key words

cascade cyclization - isatylidene malononitriles - hydroxynaphthalenes - spirobenzo[g]chromenes - spirooxindoles

• References

• 1a Smith PW, Sollis SL, Howes PD, Cherry PC, Starkey ID, Cobley KN, Weston H, Scicinski J, Merritt A, Whittington A, Wyatt P, Taylor N, Green D, Bethell R, Madar S, Fenton RJ, Morley PJ, Pateman T, Beresford A. J. Med. Chem. 1998; 41: 787
• 1b Taylor NR, Cleasby A, Singh O, Skarzynski T, Wonacott AJ, Smith PW, Sollis SL, Howes PD, Cherry PC, Bethell R, Colman P, Varghese J. J. Med. Chem. 1998; 41: 798
• 1c Takashima J, Ohsaki A. J. Nat. Prod. 2002; 65: 1843
• 1d Masukawa KM, Kollman PA, Kuntz ID. J. Med. Chem. 2003; 46: 5628
• 1e Hardcastle IR, Cockcroft X, Curtin NJ, El-Murr MD, Leahy JJ. J, Stockley M, Golding BT, Rigoreau L, Richardson C, Smith GC. M, Griffin RJ. J. Med. Chem. 2005; 48: 7829
• 1f Le Bourdonnec B, Windh RT, Leister LK, Zhou QJ, Ajello CW, Gu M, Chu G.-H, Tuthill PA, Barker WM, Koblish M, Wiant DD, Graczyk TM, Belanger S, Cassel JA, Feschenko MS, Brogdon BL, Smith SA, Derelanko MJ, Kutz S, Little PJ, DeHaven RN, DeHaven-Hudkins DL, Dolle RE. J. Med. Chem. 2009; 52: 5685
• 2a Lin AJ, Pardini RS, Cosby LA, Lillis BJ, Shansky CW, Sartorelli AC. J. Med. Chem. 1973; 16: 1268
• 2b Plyta ZF, Li T, Papageorgiou VP, Mellidis AS, Assimopoulou AN, Pitsinos EN, Couladouros EA. Bioorg. Med. Chem. Lett. 1998; 8: 3385
• 2c Kongkathip N, Luangkamin S, Kongkathip B, Sangma C, Grigg R, Kongsaeree P, Prabpai S, Pradidphol N, Piyaviriyagul S, Siripong P. J. Med. Chem. 2004; 47: 4427
• 2d Cai P, Kong F, Ruppen ME, Glasier G, Carter GT. J. Nat. Prod. 2005; 68: 1736
• 2e Izumikawa M, Satou R, Motohashi K, Nagai A, Ohnishi Y, Takagi M, Shin-ya K. J. Nat. Prod. 2011; 74: 2588

For some selected examples, see:
• 3a Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. J. Natl. Cancer Inst. 1990; 82: 1107
• 3b Yao CS, Yu CX, Li TJ, Tu SJ. Chin. J. Chem. 2009; 27: 1989
• 4a Li CJ, Averboukh L, Pardee AB. J. Biol. Chem. 1993; 268: 22463
• 4b Krishnan P, Bastow KF. Biochem. Pharmacol. 2000; 60: 1367
• 4c Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, Boothman DA. J. Biol. Chem. 2000; 275: 5416
• 4d Jassbi AR, Singh P, Jain S, Tahara S. Helv. Chim. Acta 2004; 87: 820

For some selected examples, see:
• 5a Suchý M, Kutschy P, Monde K, Goto H, Harada N, Takasugi M, Dzurilla M, Balentová E. J. Org. Chem. 2001; 66: 3940
• 5b Lo MM. C, Neumann CS, Nagayama S, Perlstein EO, Schreiber SL. J. Am. Chem. Soc. 2004; 126: 16077
• 5c Ding K, Lu Y, Nikolovska-Coleska Z, Qiu S, Ding Y, Gao W, Stuckey J, Krajewski K, Roller PP, Tomita Y, Parrish DA, Deschamps JR, Wang S. J. Am. Chem. Soc. 2005; 127: 10130
• 5d Yu S, Qin D, Shangary S, Chen J, Wang G, Ding K, McEachern D, Qiu S, Nikolovska-Coleska Z, Miller R, Kang S, Yang D, Wang S. J. Med. Chem. 2009; 52: 7970
• 5e Liu Y.-L, Wang B.-L, Cao J.-J, Chen L, Zhang Y.-X, Wang C, Zhou J. J. Am. Chem. Soc. 2010; 132: 15176
• 5f Vintonyak VV, Warburg K, Kruse H, Grimme S, Hübel K, Rauh D, Waldmann H. Angew. Chem. Int. Ed. 2010; 49: 5902
• 5g Yeung BK. S, Zou B, Rottmann M, Lakshminarayana SB, Ang SH, Leong SY, Tan J, Wong J, Keller-Maerki S, Fischli C, Goh A, Schmitt EK, Krastel P, Francotte E, Kuhen K, Plouffe D, Henson K, Wagner T, Winzeler EA, Petersen F, Brun R, Dartois V, Diagana TT, Keller TH. J. Med. Chem. 2010; 53: 5155
• 5h Ding M, Zhou F, Liu Y.-L, Wang C.-H, Zhao X.-L, Zhou J. Chem. Sci. 2011; 2: 2035

For some selected examples and reviews, see:
• 6a Enders D, Grondal C, Hüttl MR. M. Angew. Chem. Int. Ed. 2007; 46: 1570
• 6b Cheng X, Vellalath S, Goddard R, List B. J. Am. Chem. Soc. 2008; 130: 15786
• 6c Chen X.-H, Wei Q, Luo S.-W, Xiao H, Gong L.-Z. J. Am. Chem. Soc. 2009; 131: 13819
• 6d Zhou F, Liu Y.-L, Zhou J. Adv. Synth. Catal. 2010; 352: 1381
• 6e Grondal C, Jeanty M, Enders D. Nat. Chem. 2010; 2: 167
• 6f Wang X.-N, Zhang Y.-Y, Ye S. Adv. Synth. Catal. 2010; 352: 1892
• 6g Zhou J. Chem. Asian J. 2010; 5: 422
• 6h Chen W.-B, Wu Z.-J, Hu J, Cun L.-F, Zhang X.-M, Yuan W.-C. Org. Lett. 2011; 13: 2472
• 6i Cao Y, Jiang X, Liu L, Shen F, Zhang F, Wang R. Angew. Chem. Int. Ed. 2011; 50: 9124
• 6j Duce S, Pesciaioli F, Gramigna L, Bernardi L, Mazzanti A, Ricci A, Bartoli G, Bencivenni G. Adv. Synth. Catal. 2011; 353: 860
• 6k Loh CC. J, Enders D. Angew. Chem. Int. Ed. 2012; 51: 46
• 6l Bergonzini G, Melchiorre P. Angew. Chem. Int. Ed. 2012; 51: 971
• 6m Shi F, Tao ZL, Luo SW, Tu SJ, Gong LZ. Chem. Eur. J. 2012; 18: 6885
• 6n Tan B, Zeng X, Leong WW, Shi Z, Barbas III CF, Zhong G. Chem. Eur. J. 2012; 18: 63
• 6o Singh GS, Desta ZY. Chem. Rev. 2012; 112: 6104
• 6p Rios R. Chem. Soc. Rev. 2012; 41: 1060
• 6q Hong L, Wang R. Adv. Synth. Catal. 2013; 355: 1023
• 6r Liu Y.-L, Wang X, Zhao Y.-L, Zhu F, Zeng X.-P, Chen L, Wang C.-H, Zhao X.-L, Zhou J. Angew. Chem. Int. Ed. 2013; 52: 13735
• 6s Zhou F, Tan C, Tang J, Zhang Y.-Y, Gao W.-M, Wu H.-H, Yu Y.-H, Zhou J. J. Am. Chem. Soc. 2013; 135: 10994
• 6t Cao Z.-Y, Wang X, Tan C, Zhao X.-L, Zhou J, Ding K. J. Am. Chem. Soc. 2013; 135: 8197
• 6u Cao Z.-Y, Zhou F, Yu Y.-H, Zhou J. Org. Lett. 2013; 15: 42

For some selected examples, see:
• 7a Bella M, Gasperi T. Synthesis 2009; 1583
• 7b Zhao H, Lan Y.-B, Liu Z.-M, Wang Y, Wang X.-W, Tao J.-C. Eur. J. Org. Chem. 2012; 1935

For some selected examples, see:
• 8a Katritzky AR, Pilarski B, Urogdi L. Synthesis 1989; 949
• 8b Mukherjee C, Zhu D, Biehl ER, Hua L. Eur. J. Org. Chem. 2006; 5238
• 8c Fernandes BC. M, Mateo C, Kiziak C, Chmura A, Wacker J, van Rantwijk F, Stolz A, Sheldon RA. Adv. Synth. Catal. 2006; 348: 2597
• 8d Haddenham D, Pasumansky L, DeSoto J, Eagon S, Singaram B. J. Org. Chem. 2009; 74: 1964
• 9a Chen W.-B, Wu Z.-J, Pei Q.-L, Cun L.-F, Zhang X.-M, Yuan W.-C. Org. Lett. 2010; 12: 3132
• 9b Enders D, Urbanietz G, Raabe G. Synthesis 2011; 1905
• 9c Jiang X, Sun Y, Yao J, Cao Y, Kai M, He N, Zhang X, Wang Y, Wang R. Adv. Synth. Catal. 2012; 354: 917
• 10a Estévez R, Barcia J, Otero J, Estévez J. Synlett 2007; 1399
• 10b Rueping M, Sugiono E, Merino E. Angew. Chem. Int. Ed. 2008; 47: 3046
• 10c Zhou W.-M, Liu H, Du D.-M. Org. Lett. 2008; 10: 2817
• 10d Rueping M, Parra A, Uria U, Besselièvre F, Merino E. Org. Lett. 2010; 12: 5680
• 10e Wang Y.-F, Zhang W, Luo S.-P, Zhang G.-C, Xia A.-B, Xu X.-S, Xu D.-Q. Eur. J. Org. Chem. 2010; 4981
• 10f Westermann B, Ayaz M. Synlett 2010; 1489
• 10g Gao Y, Ren Q, Ang S.-M, Wang J. Org. Biomol. Chem. 2011; 9: 3691
• 10h Wu R, Chang X, Lu A, Wang Y, Wu G, Song H, Zhou Z, Tang C. Chem. Commun. 2011; 47: 5034
• 10i Enders D, Yang X, Wang C, Raabe G, Runsink J. Chem. Asian J. 2011; 6: 2255
• 10j Enders D, Wang C, Yang X, Raabe G. Adv. Synth. Catal. 2010; 352: 2869

For some selected examples of isatylidene malononitriles acting as Michael acceptors, see:
• 11a Higashiyama K, Otomasu H. Chem. Pharm. Bull. 1980; 28: 1540
• 11b Hari Babu T, Abragam Joseph A, Muralidharan D, Perumal PT. Tetrahedron Lett. 2010; 51: 994
• 11c Deng H.-P, Wei Y, Shi M. Org. Lett. 2011; 13: 3348
• 11d Lan Y.-B, Zhao H, Liu Z.-M, Liu G.-G, Tao J.-C, Wang X.-W. Org. Lett. 2011; 13: 4866

For racemic synthesis of the desired products, see:
• 12a Ghahremanzadeh R, Amanpour T, Bazgir A. J. Heterocycl. Chem. 2009; 46: 1266
• 12b Mobinikhaledi A, Foroughifar N, Fard MA. B. Synth. Commun. 2011; 41: 441

For some selected examples and reviews, see:
• 13a Okino T, Hoashi Y, Takemoto Y. J. Am. Chem. Soc. 2003; 125: 12672
• 13b Li B.-J, Jiang L, Liu M, Chen Y.-C, Ding L.-S, Wu Y. Synlett 2005; 603
• 13c Vakulya B, Varga S, Csámpai A, Soós T. Org. Lett. 2005; 7: 1967
• 13d Song J, Wang Y, Deng L. J. Am. Chem. Soc. 2006; 128: 6048
• 13e Doyle AG, Jacobsen EN. Chem. Rev. 2007; 107: 5713
• 13f Palacio C, Connon SJ. Org. Lett. 2011; 13: 1298
• 13g Varga S, Jakab G, Drahos L, Holczbauer T, Czugler M, Soós T. Org. Lett. 2011; 13: 5416
• 13h Curti C, Rassu G, Zambrano V, Pinna L, Pelosi G, Sartori A, Battistini L, Zanardi F, Casiraghi G. Angew. Chem. Int. Ed. 2012; 51: 6200
• 13i Geng Z.-C, Li N, Chen J, Huang X.-F, Wu B, Liu G.-G, Wang X.-W. Chem. Commun. 2012; 48: 4713
• 14 CCDC 938323 (4e) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. See the Supporting Information for details.
• 15 Raghuvanshi DS, Singh KN. ARKIVOC 2010; (x): 305
• 16 CCDC 941300 (5) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. See the Supporting Information for details
• 17a Zuend SJ, Jacobsen EN. J. Am. Chem. Soc. 2009; 131: 15358
• 17b Cui H.-L, Chen Y.-C. Chem. Commun. 2009; 4479
• 17c Enders D, Urbanietz G, Hahn R, Raabe G. Synthesis 2012; 44: 773
• 17d Liu Y.-L, Zhou J. Chem. Commun. 2012; 48: 1919
• 17e Jiang X, Sun Y, Yao J, Cao Y, Kai M, He N, Zhang X, Wang Y, Wang R. Adv. Synth. Catal. 2012; 354: 917